Methylprednisolone Sodium Succinate


Methylprednisolone Sodium Succinate

Drug - Methylprednisolone Sodium Succinate
The trade name of the product as shown on the labeling.

The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Methylprednisolone Sodium Succinate
Multiple ingredients are in alphabetical order.

Strength - EQ 1GM BASE/VIAL
The potency of the active ingredient(s), Methylprednisolone Sodium Succinate. May repeat for multiple part products.

Applicant - AM PHARM
The firm name holding legal responsibility for Methylprednisolone Sodium Succinate. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 040612
The FDA assigned number to Methylprednisolone Sodium Succinate. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Methylprednisolone Sodium Succinate. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AP
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Aug 12, 2004
The date Methylprednisolone Sodium Succinate was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Methylprednisolone Sodium Succinate. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Methylprednisolone Sodium Succinate is in. Format is RX, OTC, DISCN.

Applicant Full Name - American Pharmaceutical Partners Inc
The full name of the firm holding legal responsibility for the new application of Methylprednisolone Sodium Succinate.

Methylprednisolone Sodium Succinate